Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Pharmaceutical

Key Companies in the MEA Anti Fungal Agents Market

Pharmaceutical industry in the Middle East and Africa region includes companies involved in the research, development, manufacturing, and distribution of anti-fungal agents. These medications are used to treat various fungal infections. 

Report ID: MRFR/Pharma/1942-HCR | Pages: 84 | Author: Satyendra Maurya, Rahul Gotadki | Updated: February 16, 2025
Request Free Sample
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the MEA Anti Fungal Agents Market

MEA Anti-Fungal Agents Key Companies

Latest MEA Anti-Fungal Agents Companies Update

 Pfizer collaborates with the Egyptian Ministry of Health to launch a program for early diagnosis and treatment of fungal infections in high-risk groups.

Roche enters into a partnership with a Moroccan pharmaceutical company to distribute its antifungal drug, Posaconazole, in the region.

Glenmark Pharmaceuticals launches Itraconazole capsules in Kenya, expanding access to a first-line antifungal medication for patients with blastomycosis.

Janssen Pharmaceuticals launches Isavuconazole in South Africa, offering a broad-spectrum antifungal agent for the treatment of various fungal infections

List of MEA Anti-Fungal Agents Key Companies in the Market

  • Novartis AG
  • Pfizer Inc.
  • Sanofi-Aventis
  • Merck & Co. Inc.
  • Enzon Pharmaceuticals Inc.
  • Bayer AG
  • Astellas Pharma Inc.
  • GlaxoSmithKline plc
  • Abbott
  • Sigma-Aldrich